 |
September 27-30, 2010
Sheraton Denver Downtown
Denver, CO
VIEW PROGRAM
Underwriting Supporter
|
Recent advances in genomics, proteomics, molecular imaging, and other new technologies are leading to a molecularly based reclassification of malignancy. These same approaches also afford an opportunity to view the relevance of individual therapeutic targets in a broader biological context. This emerging understanding, together with the enhanced ability to characterize tumors from individual patients, creates many opportunities for improved treatment of malignancy and accelerated development of new therapeutics. Despite these extraordinary opportunities, significant hurdles—scientific, technological, organizational, and economic—stand in the way of rapid and broad adoption of this approach. This meeting will explore the promise of this biologically based approach to therapeutic development and clinical investigations, review the current state of accomplishments in these areas, and discuss solutions to some of the challenges as well as the resulting future advancements. We hope you will join us in Denver for this exciting conference.
PROGRAM COMMITTEE CHAIRPERSON:
Gordon B. Mills, UT M. D. Anderson Cancer Center, Houston, TX
PROGRAM COMMITTEE CO-CHAIRPERSONS:
Mehmet Toner, Harvard Medical School, Charlestown, MA
Barbara L. Weber, Novartis Institutes for BioMedical Research, Cambridge, MA
PROGRAM COMMITTEE:
Adriana Albini, IRCCS Multimedica, Milan, Italy
Sangeeta N. Bhatia, Massachusetts Institute of Technology, Cambridge, MA
George A. Calin, UT M. D. Anderson Cancer Center, Houston, TX
Stephen J. Chanock, National Cancer Institute, Bethesda, MA
Peter S. Conti, USC Keck School of Medicine, Los Angeles, CA
Jonathan A. Fletcher, Brigham and Women's Hospital, Boston, MA
Peter Kuhn, The Scripps Research Institute, La Jolla, CA
Edison T. Liu, Genome Institute of Singapore, Singapore
Pier Paolo Pandolfi, Harvard University, Boston, MA
Jane Perlmutter, Gemini Group, Ann Arbor, MI
Michael K. Samoszuk, Ortho Clinical Diagnostics, Raritan, NJ
Jennifer West, Rice University, Houston, TX